A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam
dc.contributor.author | Snyder, Peter J. | en_US |
dc.contributor.author | Feltner, Douglas E. | en_US |
dc.contributor.author | Caveney, Angela F. | en_US |
dc.contributor.author | Giordani, Bruno | en_US |
dc.contributor.author | Maruff, Paul | en_US |
dc.contributor.author | Werth, John | en_US |
dc.date.accessioned | 2006-09-11T17:42:23Z | |
dc.date.available | 2006-09-11T17:42:23Z | |
dc.date.issued | 2006-05 | en_US |
dc.identifier.citation | Maruff, Paul; Werth, John; Giordani, Bruno; Caveney, Angela F.; Feltner, Douglas; Snyder, Peter J.; (2006). "A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam." Psychopharmacology 186(1): 7-17. <http://hdl.handle.net/2027.42/46374> | en_US |
dc.identifier.issn | 1432-2072 | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46374 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16572266&dopt=citation | en_US |
dc.description.abstract | The effects of any drug treatment on cognitive function are typically studied in groups of subjects. Observations made about the behavior of the drug, in the study sample, are then generalized to the population from which the sample was drawn. However, the magnitude and pharmacodynamic qualities of the response to many central nervous system-active drugs are known to vary in the population. Therefore, it is useful to consider statistical models for the detection of cognitive change in response to a drug treatment in individual subjects. | en_US |
dc.format.extent | 174973 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.title | A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Section of Neuropsychology, Department of Psychiatry, University of Michigan School of Medicine, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationum | Section of Neuropsychology, Department of Psychiatry, University of Michigan School of Medicine, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationother | Department of Psychology, University of Connecticut (Storrs, CT) & CNS Early Development, Pfizer Global Research & Development, Groton, CT, USA, | en_US |
dc.contributor.affiliationother | CogState Ltd, Melbourne, Australia, | en_US |
dc.contributor.affiliationother | CNS Early Development, Pfizer Global Research & Development, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationother | CNS Early Development, Pfizer Global Research & Development, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 16572266 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46374/1/213_2006_Article_331.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s00213-006-0331-5 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.